Cerebral Vasospasm
Information
- Disease name
- Cerebral Vasospasm
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02056769 | Active, not recruiting | N/A | CT Perfusion Imaging to Predict Vasospasm in Subarachnoid Hemorrhage | April 2014 | February 2024 |
| NCT02775318 | Completed | Phase 1 | Stellate Ganglion Block Using Ultrasound Guidance For Treatment Of Post Clipping Cerebral Vasospasm | September 2014 | July 2015 |
| NCT03611790 | Completed | N/A | Vesalio NeVa VS for Symptomatic Cerebral Vasospasm Following aSAH (The VITAL Study) | December 19, 2018 | May 31, 2021 |
| NCT03214705 | Completed | Role of CT Perfusion in Predicting Poor Outcome After Subarachnoid Hemorrhage | March 1, 2016 | February 28, 2018 | |
| NCT03517670 | Completed | Safety of Intravenous Milrinone for the Treatment of Subarachnoid Hemorrhage-induced Vasospasm | August 31, 2020 | August 31, 2020 | |
| NCT00962546 | Completed | Computed Tomographic (CT) Perfusion and CT Angiography as Screening Tools for Vasospasm Following Subarachnoid Hemorrhage | September 2009 | December 2011 | |
| NCT01024972 | Completed | Phase 1/Phase 2 | Safety Study of Dantrolene in Subarachnoid Hemorrhage | October 2009 | October 2013 |
| NCT04208477 | Completed | N/A | "The Effect of Stellate Ganglion Block in Severe Brain Injury" | November 1, 2021 | December 31, 2023 |
| NCT00692744 | Completed | Quality of Life in Elderly After Aneurysmal Subarachnoid Hemorrhage (SAH) | October 2008 | January 2014 | |
| NCT01595802 | Completed | Non-Significant Risk Study Comparing the Nautilus NeuroWaveTM to Transcranial Doppler as an Aid to Diagnosing Vasospasm | January 2012 | July 2015 | |
| NCT01799018 | Completed | Role of Proteomics and Metallomics in Cerebral Vasospasm Following Subarachnoid Hemorrhage | April 2011 | June 2013 | |
| NCT00839449 | Completed | Phase 4 | Eicosapentaenoic Acid Cerebral Vasospasm Therapy Study | December 2004 | December 2008 |
| NCT02275949 | Completed | N/A | Acupuncture for Cerebral Vasospasm After Subarachnoid Hemorrhage | September 2014 | June 2017 |
| NCT02389634 | Completed | Identification of Novel Molecular Markers for Vasospasm | September 2010 | October 25, 2019 | |
| NCT01158508 | Completed | Phase 1 | Remote Ischemic Preconditioning in Subarachnoid Hemorrhage | April 2010 | July 2014 |
| NCT01187420 | Completed | Bilateral Bispectral Index (BIS) Study | June 2009 | October 2010 | |
| NCT05230134 | Enrolling by invitation | N/A | Cervical Sympathetic Block in Patients With Cerebral Vasospasm | July 27, 2023 | December 2024 |
| NCT04613960 | Not yet recruiting | Phase 2/Phase 3 | Magnesium Treating Subarachnoid Hemorrhage Vasospasm | December 2022 | June 2024 |
| NCT05150002 | Recruiting | N/A | Cervical Spinal Cord Stimulation in Patients With Cerebral Vasospasm After Subarachnoid Haemorrhage: VasoStim Study | June 30, 2023 | September 2027 |
| NCT01996436 | Recruiting | Phase 4 | The Intra-arterial Vasospasm Trial | August 29, 2016 | December 2024 |
| NCT06303349 | Recruiting | N/A | Predictive Model for the Occurrence of Cerebral Vasospasm Complicating Subarachnoid Haemorrhage by Combined Analysis of the Kinetics of a Panel of Biomarkers. | May 7, 2024 | June 2025 |
| NCT04691271 | Recruiting | N/A | Stellate Ganglion Block and Cerebral Vasospasm | July 1, 2021 | December 30, 2024 |
| NCT00487461 | Terminated | N/A | Use of Simvastatin for the Prevention of Vasospasm in Aneurysmal Subarachnoid Hemorrhage | May 2007 | June 2009 |
| NCT00582868 | Terminated | Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH | May 2007 | May 2009 | |
| NCT00585559 | Terminated | Phase 3 | Acetaminophen in aSAH to Inhibit Lipid Peroxidation and Cerebral Vasospasm | April 2007 | October 26, 2023 |
| NCT01343537 | Terminated | Early Phase 1 | Continuous Neurophysiological Monitoring Detection of Cerebral Vasospasm in Aneurysmal Subarachnoid Hemorrhage Subjects | December 2010 | March 2014 |
| NCT01810302 | Terminated | Phase 2 | Safety Study of Nicardipine to Treat Cerebral Vasospasm | August 2013 | January 2014 |
| NCT02712788 | Terminated | Phase 2 | Milrinone in Addition to Hyperdynamic Therapy in the Treatment of Vasospasm Following Aneurysmal Subarachnoid Hemorrhage | April 18, 2016 | May 3, 2018 |
| NCT03028298 | Unknown status | Phase 1 | Sildenafil for DCI | December 2016 | July 2023 |
| NCT02432157 | Unknown status | Phase 1/Phase 2 | Safety and Feasibility of Hypertonic Saline Solution After Aneurysmal Subarachnoid Hemorrhage: | January 2015 | |
| NCT04512859 | Unknown status | N/A | Stellate Ganglion Block in Preventing Cerebral Vasospasm Secondary to Subarachnoid Hemorrhage | September 1, 2020 | December 31, 2022 |
| NCT02129413 | Unknown status | N/A | Safety Study of Carotid Body Neurostimulation to Treat Cerebral Vasospasm | May 2014 | |
| NCT00871065 | Withdrawn | Phase 2 | Safety Study of Sildenafil in Treatment of Cerebral Aneurysm Vasospasm | July 2008 | February 25, 2009 |
| NCT01878136 | Withdrawn | Phase 1/Phase 2 | Effect of Intraventricular tPA Following Aneurysmal Subarachnoid Hemorrhage | March 2015 | September 2016 |
| NCT01091870 | Withdrawn | Phase 2 | Sildenafil for Prevention of Cerebral Vasospasm | March 2010 | |
| NCT02426827 | Withdrawn | N/A | Cervical Spinal Cord Stimulation in Cerebral Vasospasm | July 2016 | April 2018 |